We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2021.
Outcomes from the first meeting with the regulators of medicine who had met globally to discuss dementia.
Outlines the level of payment due from members of the Pharmaceutical Price Regulation Scheme (PPRS) in 2018.
Information for healthcare professionals, patients, and the public.
Guidance and change control form to request a change to an Advisory Committee on Borderline Substances (ACBS) application form and/or guidance.
We use decades of experience in safe bioagent handling to support partners in research, development and testing of vaccines and therapeutics
Patient communication about a very low risk to patient safety in response to the field safety notice (FSN) issued by Diffuplast and MHRA.
How equipment for temperature screening is regulated, the limitations of temperature screening for detecting COVID-19 and advice on buying and using these products.
UK businesses can apply for a share of up to £8 million from the Industrial Strategy Challenge Fund for capital projects to improve medicines manufacturing.
Data submission requirements for acute, community and private microbiology services submitting data on all LA/NHS chlamydia tests done in England.
Guidance for healthcare professionals on providing free prescriptions for participants in the HEAL-COVID or STIMULATE-ICP long COVID clinical trials.
MHRA scientific and regulatory advice for COVID-19 vaccine developers
Information for local authorities in England about the grant, which will support local authorities to deliver routine commissioning of PrEP in 2020 to 2021.
Submitting notifications on the European common entry gate for Northern Ireland for suppliers of e-cigarettes and e-liquids.
Acceptable naming, presentation and packaging of nicotine-containing electronic cigarettes and refill containers.
Information about the types of content published by the MHRA.
Report showing opportunities and challenges for community pharmacy teams to further support the public’s health.
Types of ingredients permitted in nicotine-containing liquids in electronic cigarettes and refill containers.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2020.
General advice on due diligence - electronic cigarettes devices and refill containers.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).